| D010403 |
Penicillin Resistance |
Nonsusceptibility of an organism to the action of penicillins. |
Penicillin Resistances,Resistance, Penicillin,Resistances, Penicillin |
|
| D002510 |
Cephalosporinase |
|
beta-Lactamase II,Cephalexin Amidase,Cephalosporin Amido-beta-Lactam Hydrolase,Cephalosporin beta-Lactamase,Amidase, Cephalexin,Amido-beta-Lactam Hydrolase, Cephalosporin,Cephalosporin Amido beta Lactam Hydrolase,Cephalosporin beta Lactamase,Hydrolase, Cephalosporin Amido-beta-Lactam,beta Lactamase II,beta-Lactamase, Cephalosporin |
|
| D004009 |
Dicloxacillin |
One of the PENICILLINS which is resistant to PENICILLINASE. |
Dichloroxacillin,Cilpen,Diclocil,Dicloxaciclin,Dicloxacillin Sodium,Dicloxacillin, Monosodium Salt, Anhydrous,Dicloxacillin, Monosodium Salt, Mono-Hydrate,Dicloxacycline,Dicloxsig,Distaph,Ditterolina,Dycill,Dynapen,InfectoStaph,Pathocil,Posipen,Sodium, Dicloxacillin |
|
| D004338 |
Drug Combinations |
Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. |
Drug Combination,Combination, Drug,Combinations, Drug |
|
| D004357 |
Drug Synergism |
The action of a drug in promoting or enhancing the effectiveness of another drug. |
Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug |
|
| D000667 |
Ampicillin |
Semi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic. |
Penicillin, Aminobenzyl,Amcill,Aminobenzylpenicillin,Ampicillin Sodium,Ampicillin Trihydrate,Antibiotic KS-R1,Omnipen,Pentrexyl,Polycillin,Ukapen,Aminobenzyl Penicillin,Antibiotic KS R1,KS-R1, Antibiotic,Sodium, Ampicillin,Trihydrate, Ampicillin |
|
| D001441 |
Bacteroides fragilis |
Gram-negative bacteria occurring in the lower intestinal tracts of man and other animals. It is the most common species of anaerobic bacteria isolated from human soft tissue infections. |
|
|